Proteomic signatures of corona and herpes viral antibodies identify IGDCC4 as a mediator of neurodegeneration.

Publication date: May 30, 2025

Mechanisms underlying the dynamic relationships of viral infections and neurodegeneration warrant examination. Using a community-based cohort of older adults, the current study characterized the neurocognitive (cognitive functioning, brain volumes, Alzheimer’s disease positron emission tomography, and plasma biomarkers) and plasma proteomic (7268 proteins) profiles of four common coronavirus and six herpesvirus antibody titers. Genetic inference techniques demonstrated the associations between viral antibody titers and neurocognitive outcomes may be attributed to altered expression in a subset of mechanistically relevant proteins in plasma. One of these proteins, IGDCC4 (immunoglobulin superfamily deleted in colorectal cancer subclass member 4), was related to 20-year dementia risk, cognitive functioning, and amyloid-β positivity using data from two independent cohorts, while its plasma and intrathecal abundance were causally implicated in dementia risk and clinically relevant brain atrophy. Our findings illuminate the biological basis by which host immune responses to viruses may affect neurocognitive outcomes in older adults and identify IGDCC4 as an important molecular mediator of neurodegeneration.

Open Access PDF

Concepts Keywords
Amyloid Aged
Herpesvirus Aged, 80 and over
Older Alzheimer Disease
Proteins Amyloid beta-Peptides
Tomography Amyloid beta-Peptides
Antibodies, Viral
Antibodies, Viral
Biomarkers
Biomarkers
Brain
Female
Herpesviridae
Humans
Male
Neurodegenerative Diseases
Proteomics

Semantics

Type Source Name
disease MESH viral infections
disease MESH Alzheimer’s disease
disease MESH colorectal cancer
pathway KEGG Colorectal cancer
disease MESH dementia
disease IDO host
disease MESH infections
disease MESH sepsis
disease MESH pneumonia
disease MESH Neurodegenerative Disease
pathway REACTOME Neurodegenerative Diseases
drug DRUGBANK Trestolone
disease MESH Neurological Disorders
disease MESH Stroke
disease MESH syndrome
disease MESH SARS CoV 2 infection
disease MESH herpes simplex
disease MESH herpesvirus infection
disease IDO infection
disease MESH urinary tract infection
disease IDO blood
disease MESH Atherosclerosis
drug DRUGBANK Coenzyme M
disease MESH etiology
drug DRUGBANK Esomeprazole
disease MESH measles
pathway KEGG Measles
disease IDO bacteria
drug DRUGBANK Ilex paraguariensis leaf
disease MESH tauopathy
pathway KEGG Alzheimer disease

Original Article

(Visited 1 times, 1 visits today)